I will be happy if they never use the words "excited" or "promising" again in a future PR. I understand there are good reasons to try and manage the company's image and progress in order to keep the fire simmering underneath (especially on the OTC), but as you rightfully imply this can backfire if used excessively, and in the absence of tangible progress.

Don't get me wrong, the Poly acquisition and 20M from Aspire are nothing to sneeze at. Now we need to see INDs and Board appointments.

Both Ehrlich and Menon have a flair for using dramatic language, and I would suggest they look at the tempered remarks used by other successful biotech managers, who allow their good results and execution to do the talking.